Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × binimetinib × Breast × Clear all

Phase

Status

Sponsor Class

NIH 3 OTHER 2 INDUSTRY 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 3 CNS 1 Breast 1

Conditions

Triple Negative Breast Neoplasms 1

Interventions

Cyclophosphamide 42 Docetaxel 33 Paclitaxel 31 Tamoxifen 29 Doxorubicin 29 Trastuzumab 24 Radiotherapy 20 Epirubicin 16 Letrozole 15 Anastrozole 12 exemestane 11 Fluorouracil 11 Capecitabine 10 Bevacizumab 10 palbociclib 9 Immunohistochemistry 9 Fulvestrant 9 Filgrastim 9 Lapatinib 8 Methotrexate 7 Gene Expression Profiling 7 Zoledronic Acid 6 Triptorelin Pamoate 6 Taxes 6 Surgical Procedures, Operative 6 Microarray Analysis 6 Magnetic Resonance Spectroscopy 6 Goserelin 6 Carboplatin 6 Amplified Fragment Length Polymorphism Analysis 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04494958 2025-03-24

PALBOBIN

Fundacion Oncosur

Phase 1/2 Completed

24 enrolled 10 charts

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡